Health Sciences Authority
|Health Sciences Authority|
|Logo of HSA|
|Jurisdiction||Government of Singapore|
|Headquarters||11 Outram Road, Singapore 169078|
|Agency executives||Professor John Wong, Chairman
A/Prof John Lim, Chief Executive Officer
|Parent agency||Ministry of Health|
HSA is a multi-disciplinary agency. It applies medical, pharmaceutical and scientific expertise to protect and advance public health and safety. The organisation serves three key functions: It is the national regulator for health products; it secures the national blood supply through its operation of the national blood bank – Bloodbank@HSA; and it represents the national expertise in forensic medicine, forensic science and analytical chemistry testing capabilities. These support other regulatory and compliance agencies in the administration of justice and in safeguarding public health.
The HSA was formed on 1 April 2001 with the integration of five specialised agencies under the Ministry of Health: the Centre for Drug Evaluation; Institute of Science and Forensic Medicine; National Pharmaceutical Administration; Product Regulation Department; and Singapore Blood Transfusion Service.
Today, the agency’s professional knowledge, skills and competencies are housed in three professional groups: the Health Products Regulation Group; Blood Services Group, and Applied Sciences Group. Each group functions as Divisions comprising branches, units and laboratories. The three professional groups work with the corporate HQ that provides strategic direction and corporate support for advancing the organisation.
Health Products Regulation
The HSA’s Health Products Regulation Group ensures that medicines, medical devices and other health products available in Singapore meet appropriate and acceptable standards in quality, safety and efficacy. The agency also contributes to the formulation of national drug policies.
HSA’s risk management system takes into account pre-and-post market precautionary options. On the pre-market front, HSA administers clinical trials for new drugs and grants approvals for these products before they are marketed in Singapore. Audits on good manufacturing and distribution practices are also conducted.
On the post-market front, HSA monitors health products in the market through regulatory surveillance activities. The agency also carries out investigations and takes enforcement action against illegal activities related to unregistered, counterfeit and adulterated health products. HSA has an established and active pharmacovigilance monitoring programme that draws on its network of healthcare professionals and overseas regulators. This allows HSA to initiate targeted and prompt alert action in response to reported adverse drug events. This allows the agency to expedite the isolation of such problems and minimise harm to public health and safety.
In support of the national objective to reduce smoking, HSA enforces the laws that prohibit tobacco advertisements, smoking by youths under 18 years old as well as the sale of tobacco products to youths in this age group.
SINGAPORE GOVT PORTAL
The first-stop portal to discover publicly-available government data
- Singapore Commonly Used Chinese Terms
An on-line database of Chinese terms commonly used in Singapore
- Civil Aviation Authority of Singapore (CAAS) eServices
Application to CAAS for permit, licences and careers
Your official gateway to Singapore
- Contact Singapore
Working, investing and living in Singapore
- Singapore United
Together for a Singapore United
- Unique Entity Number (UEN)
Search for UEN of entities (e.g. businesses, societies, trade unions, etc) registered in Singapore
- Overseas Singaporeans
Information, e-services and online communities to connect overseas Singaporeans
The latest Singapore Government gazettes, notices, bills
- Singapore Public Holidays
2013 Holiday Listing